Hormones · Melatonin

Melatonin alleviates polycystic ovary syndrome, premature ovarian insufficiency, ovarian injury, and age-related ovarian function decline

This review establishes an integrated mechanistic model in which oxidative stress, mitochondrial dysfunction, inflammatory responses, and autophagic imbalance contribute to ovarian disorders, while melatonin acts as a pleiotropic regulator counteracting these pathways. The paper reports that melatonin alleviates PCOS, POI, ovarian injury, and age-related ovarian function decline, but no specific effect sizes or sample sizes are provided.

1 min read•Updated Jul 8, 2026•0 RCTs•View structured evidence →
Evidence Score32/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★☆
Confidencelow

This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.

Melatonin alleviates polycystic ovary syndrome, premature ovarian insufficiency, ovarian injury, and age-related ovarian function decline The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).

The Claim

Melatonin alleviates polycystic ovary syndrome, premature ovarian insufficiency, ovarian injury, and age-related ovarian function decline

This conclusion is most relevant to: Ovarian disorder patients (PCOS, POI, ovarian injury, age-related decline) and animal models.

What the Research Shows

The conclusion draws on 1 linked study. Highlights from the cited literature:

  • ▸Melatonin in ovarian function and dysfunction: Molecular mechanisms and therapeutic potential. (Journal of ovarian research, 2026) —

How It Works

The proposed biological pathway:

  • ▸Oxidative stress contributes to ovarian disorders
  • ▸Mitochondrial dysfunction contributes to ovarian disorders
  • ▸Inflammatory responses and autophagic imbalance contribute to ovarian disorders
  • ▸Melatonin counteracts these interconnected pathological pathways

Who Might Benefit

Evidence fit by population:

  • ▸Ovarian disorder patients (PCOS, POI, ovarian injury, age-related decline) and animal models

Limitations & Caveats

Important context when interpreting this evidence:

  • ▸This is a review paper, not a primary study, so no original experimental data are presented
  • ▸Optimal dosage, administration regimens, and therapeutic targets remain undetermined

Frequently Asked Questions

What ovarian conditions does melatonin help with?▼

Melatonin alleviates polycystic ovary syndrome (PCOS), premature ovarian insufficiency (POI), ovarian injury, and age-related ovarian function decline.

How does melatonin protect ovarian function?▼

Melatonin acts as a pleiotropic regulator that counteracts oxidative stress, mitochondrial dysfunction, inflammatory responses, and autophagic imbalance.

Is melatonin effective against ovarian tumors?▼

The review discusses recent advances regarding the inhibitory effects of melatonin on ovarian tumors, but does not provide specific efficacy data.

What is the recommended dose of melatonin for ovarian disorders?▼

The paper states that further research is needed to determine optimal dosage, so no specific dose is recommended.

References

  1. 1.Zhao X, Zhang Y, Ding K, Qiu Z, Wang Y, Yu X. “Melatonin in ovarian function and dysfunction: Molecular mechanisms and therapeutic potential..” Journal of ovarian research, 2026. PMID: 42399726 DOI: 10.1186/s13048-026-02188-6
Disclaimer: This article is auto-generated from structured research data for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.